ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Mihich Recommendation for Antigen Development In BRMP Summarized

December 14, 1979

Cancer Control Grows Up Fast As It Moves To Meet Mandate, Take Over Big Part Of NCI Budget

March 15, 1974

Six Years into The Drug Shortage, And The Causes Are Still a Mystery

October 14, 2011

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Senate Approves FY08 Labor-HHS Appropriations.

October 26, 2007